Device Trial Radar · NCT04381767
EYE-SYNC Concussion Classification Study
Last checked: Nov 19, 2026Latest source record: Jun 25, 2020 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
1,303
Actual
Start
Dec 19, 2018
Primary completion
Mar 23, 2020
Study completion Jun 23, 2020
Sponsor
- Lead sponsor
- Sync-Think, Inc.Not on our public-company list
- Sponsor type
- Industry
- First posted
- May 11, 2020
Design
- Study type
- Observational
- FDA-regulated device
- Yes
- Who can join
- All sexes, from 17 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The purpose of this study is to determine the sensitivity and specificity of an aid in assessment of concussion based on eye-tracking, in comparison to a clinical reference standard appropriate for sport-related concussion evaluation.
Conditions
- Concussion, Mild
- Concussion; Eye
- Concussion, Brain
- Concussion, Severe
- Brain Injuries
- Concussion, Cerebral
Interventions
EYE-SYNCDevice
Evaluation of oculomotor performance using visual presentation and eye tracking analysis
Primary outcomes
What the sponsor says the trial is designed to measure.
- A change in metrics of eye movement that enable positive concussion detection using EYE-SYNC metricsTime frame: 3 days
Locations
1 site in 1 country. Site status is shown where the registry gives one.
Sync-Think, Inc.
Palo Alto, California
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.